- Advertisement -
Needle-free vaccine company Vaxxas is being supported by a US Government contract worth US$28.5 million ($43 million) to conduct a bird flu vaccine trial in Queensland and Victoria in the largest Phase http://www.businessnewsaustralia.com/1 clinical study to date for the Brisbane-based…
